Health
Argonne’s Advanced Photon Source guided the development of new COVID-19 vaccine now in trials – News-Medical.net
Human clinical trials have begun on a new vaccine candidate that may protect against not only SARS-CoV-2, the virus that causes COVID-19, but against at least two…
Human clinical trials have begun on a new vaccine candidate that may protect against not only SARS-CoV-2, the virus that causes COVID-19, but against at least two of the variants emerging around the world. The development of this new vaccine was guided by structural information on the virus obtained at the Advanced Photon Source (APS), a U.S. Department of Energy (DOE) Office of Science User Facility at DOE’s Argonne National Laboratory, and other light sources.
Trials are taking place at the Walter…
-
Noosa News15 hours agoBrisbane vs Collingwood live blog: Richmond selects Noah Balta as unbeaten Lions prepare for Magpies test
-
General14 hours agoNT Coalition candidate Lisa Siebert diverges from Jacinta Nampijinpa Price on royal commission call
-
General16 hours agoCanberra man named as doctor accused of rape after suppression order lifted
-
Noosa News18 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate